Trial intelligence / Profile preview

Dasatinib plus intensive chemotherapy for newly diagnosed core-binding factor acute myeloid leukemia

ChiCTR-IPR-15006862Phase 3Not yet recruiting

Sponsor

Ruijin Hospital

Start

Sep 2015

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1